Attitudes and perceptions of Jordanian pharmacy students toward deprescribing: a cross-sectional study

Main Article Content

Shatha M. Al Omari https://orcid.org/0000-0002-6085-7538
Hamza Alhamad https://orcid.org/0000-0002-9309-4565
Muna Barakat https://orcid.org/0000-0002-7966-1172
Hana M. Sawan https://orcid.org/0000-0001-5176-9811
Marcia C. Mecca https://orcid.org/0000-0003-4392-9963
F. Al Bahar https://orcid.org/0000-0002-4302-6636

Keywords

Deprescribing, Education, Geriatrics, Pharmacy, Polypharmacy, Survey research

Abstract

Objective: Pharmacists are in a unique position to identify medications that should be deprescribed. Including deprescribing as part of medical and pharmacy curriculum has been proposed as a substantial change to increase the practice of deprescribing. The aims of this study were to evaluate if pharmacy students were exposed to the term of deprescribing in their classes and how they were taught about it (e.g., lecture, case problems, experiential). We also aimed to assess the deprescribing knowledge, attitudes, abilities, and confidence of pharmacy students in Jordan. Methods: An electronic survey was distributed to third- and fourth-year pharmacy students at 12 schools of pharmacy. The survey included three sections, including (i) demographics and questions on their exposure to deprescribing and other experiences within their curriculum; (ii) questions regarding their attitudes, ability, and confidence regarding deprescribing, and (iii) questions to assess the factors that may influence the deprescribing process from the students’ perspectives. Study responses were extracted from Google Form® as an Excel sheet and exported into Statistical Package for Social Sciences version 24.0 (SPSS Inc., Armonk, NY: IBM Corp, USA) for statistical analyses. Descriptive statistics, including frequency and proportions, were calculated and reported appropriately. Results: Around half of the participating students (n=202, 49.5%) were familiar with the term "Deprescribing," and only 74 (18.1%) students reported exposure to deprescribing instruction through required coursework. Less than half (n=193, 47.3%) reported exposure during elective courses, and fewer (n=47, 11.5%) reported exposure in both required and elective courses. Less than half of the students (n=191, 46.8%) were confident to recommend deprescribing strategies for health care providers in patients with potentially inappropriate medications. Conclusion: The results of this study revealed that pharmacy students' attitudes and perceptions about deprescribing were generally positive, however, For didactic and experiential training, pharmacy schools should assess their curricula and consider adding content and assessment of deprescribing knowledge and skills.

Abstract 575 | PDF Downloads 513

References

1. Khan N, Chattopadhyay K, Leonardi-bee J. Incidence, prevalence, risk factors and health consequences of polypharmacy in adults in South Asia: a systematic review protocol. JBI Evid Synth. 2019;17(11):2370-2377. https://doi.org/10.11124/
JBISRIR-D-18-00001
2. Elbeddini A. Deprescribing for all: A narrative review identifying inappropriate polypharmacy for all ages in hospital settings. BMJ Open Qual. 2021;10(3):1-7. https://doi.org/10.1136/bmjoq-2021-001509 
3. Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https://doi.org/10.1186/s12877-017-0621-2
4. Caughey GE. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract. 2010;87(3):385-393. https://doi.org/10.1016/j.diabres.2009.10.019
5. Caughey GE. Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf. 2010;19(9):977-982. https://doi.org/10.1002/pds.2009
6. Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. Mt Sinai J Med. 2011;78(4):613-626. https://doi.org/10.1002/ msj.20278
7. Clark CM. Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study. Pharmacy. 2020;8(4):220. https://doi.org/10.3390/pharmacy8040220
8. Thomas JM. Development and validation of a polypharmacy knowledge assessment instrument. Am J Pharm Educ. 2019;83(5):6435. https://doi.org/10.5688/ajpe6435
9. Reeve E, Gnjidic D, Long J, et al. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: 
Implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254-1268. https://doi.org/10.1111/ bcp.12732 
10. Scott IA. Reducing Inappropriate Polypharmacy: The Process of Deprescribing. JAMA Intern Med. 2015;175(5):827-834.
https://doi.org/10.1001/jamainternmed.2015.0324
11. Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. Am Fam Physician. 2019;99(1):7-9. 
12. Schwinghammer TL. The 2016 ACCP Pharmacotherapy Didactic Curriculum Toolkit. Pharmacother J Hum Pharmacol Drug Ther. 2016;36(11):e189-e194. https://doi.org/10.1002/phar.1846
13. Flannery AH. 2019 Update to the American College of Clinical Pharmacy Pharmacotherapy Didactic Curriculum Toolkit. JACCP J Am Coll Clin Pharm. 2020;3(2):455-464. https://doi.org/10.1002/jac5.1178
14. Raman-Wilms L, Farrell B, Sadowski C, et al. Deprescribing: An educational imperative. Res Soc Adm Pharm. 2019;15(6):790- 795. https://doi.org/10.1016/j.sapharm.2018.08.011
15. Martin P, Tamblyn R, Benedetti A, et al. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication  Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial. JAMA. 2018;320(18):1889-1898. https://doi.
org/10.1001/jama.2018.16131
16. Ammerman CA, Simpkins BA, Warman N, et al. Potentially Inappropriate Medications in Older Adults: Deprescribing with a Clinical Pharmacist. J Am Geriatr Soc. 2019;67(1):115-118. https://doi.org/10.1111/jgs.15623
17. Navy HJ, Weffald L, Delate T, et al. Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam. Consult Pharm J Am Soc Consult Pharm. 2018;33(12):711-722. https://doi.org/10.4140/TCP.n.2018.711
18. Lasota ST, Merrey W, Ross PA, et al. Provider Responsiveness to Pharmacist Recommendations in a Population Health Setting. Pharm. 2019;34(5):308-316. https://doi.org/10.4140/tcp.n.2019.308
19. Swieczkowski D, Merks P, Gruchala M, et al. The role of the pharmacist in the care of patients with cardiovascular diseases. Kardiol Pol. 2016;74(11):1319-1326. https://doi.org/10.5603/KP.a2016.0136
20. Wiegand H, Kish L. Survey Sampling. John Wiley \& Sons, Inc., New York, London 1965, IX + 643 S., 31 Abb., 56 Tab., Preis 83 s. Biom. Z. 1968;10:88-89.
21. Nusair MB, Alhamad H, Mukattash T, et al. Pharmacy students’ attitudes to provide rational pharmaceutical care: A multiinstitutional study in Jordan. J Pharm Sci. 2021;14(1):27-36.
22. Al-Daghastani T, Tadros O, Arabiyat S, et al. Pharmacists’ perception of the coronavirus pandemic (Covid-19) in Jordan: A crosssectional study. Int J Environ Res Public Health. 2021;18(21):11541. https://doi.org/10.3390/ijerph182111541
23. Coe A, Kaylor-Hughes C, Fletcher S, et al. Deprescribing intervention activities mapped to guiding principles for use in general practice: A scoping review. BMJ Open. 2021;11(9):e052547. https://doi.org/10.1136/bmjopen-2021-052547
24. Barne N, Jubraj B, Grant D, et al. Medication review, polypharmacy and deprescribing: Results of a pilot scoping exercise in undergraduate and postgraduate education. Pharm Educ. 2021;21(1):126-132. https://doi.org/10.46542/pe.2021.211.126132
25. Peletidi A, Troullaki M. Abstracts. Int J Pharm Pract. 2020;28(1):5-39. 
26. Poots AJ, Jubraj B, Ward E, et al. Education around medication review and deprescribing: a survey of medical and pharmacy students’ perspectives. Ther Adv Drug Saf. 2020;11:2042098620909610. https://doi.org/10.1177/2042098620909610
27. Springer SP, Cernasev A, Barenie RE, et al. “I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing. Geriatr. 2022;7(3):60. https://doi.org/10.3390/geriatrics7030060
28. Institute BR. Polypharmacy and Deprescribing. 2020;48(7):468-471. https://doi.org/10.1016/j.mpmed.2020.04.003